- Home
- MDBH vs DXR Comparison
MDBH vs DXR Comparison
Compare MDBH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- DXR
- Stock Information
- Founded
- MDBH 1997
- DXR 1970
- Country
- MDBH United States
- DXR United States
- Employees
- MDBH N/A
- DXR N/A
- Industry
- MDBH
- DXR Medical/Dental Instruments
- Sector
- MDBH
- DXR Health Care
- Exchange
- MDBH Nasdaq
- DXR Nasdaq
- Market Cap
- MDBH 42.3M
- DXR 36.4M
- IPO Year
- MDBH 2023
- DXR N/A
- Fundamental
- Price
- MDBH $4.40
- DXR $7.75
- Analyst Decision
- MDBH
- DXR Strong Buy
- Analyst Count
- MDBH 0
- DXR 1
- Target Price
- MDBH N/A
- DXR $25.00
- AVG Volume (30 Days)
- MDBH 3.9K
- DXR 4.9K
- Earning Date
- MDBH 05-16-2025
- DXR 01-01-0001
- Dividend Yield
- MDBH N/A
- DXR N/A
- EPS Growth
- MDBH N/A
- DXR 86.16
- EPS
- MDBH 0.81
- DXR 0.11
- Revenue
- MDBH $2,085,644.00
- DXR $119,714.00
- Revenue This Year
- MDBH N/A
- DXR N/A
- Revenue Next Year
- MDBH N/A
- DXR N/A
- P/E Ratio
- MDBH $5.44
- DXR $71.30
- Revenue Growth
- MDBH N/A
- DXR N/A
- 52 Week Low
- MDBH $3.80
- DXR $6.55
- 52 Week High
- MDBH $12.00
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- MDBH 36.34
- DXR 51.69
- Support Level
- MDBH $4.31
- DXR $7.13
- Resistance Level
- MDBH $4.49
- DXR $7.74
- Average True Range (ATR)
- MDBH 0.10
- DXR 0.33
- MACD
- MDBH 0.07
- DXR 0.02
- Stochastic Oscillator
- MDBH 61.54
- DXR 89.04
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.